1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A national perspective on new nurse graduate transition to practice: Secondary analysis of the National Student Nurses' Association 2021 New Graduate Survey
    Journal Article

    Feeg, V. D.; Mancino, D.; Vasquez-Clarfield, B.; Garrison, C. M.; Mahler, E.; Vance, C.
    Nursing Economic$ (2022)

    Fulltext@MSK | Save
  • Application of the novel Nalu™ Neurostimulation System for peripheral nerve stimulation
    Review

    Kalia, H.; Pritzlaff, S.; Li, A. H.; Ottestad, E.; Gulati, A.; Makous, J.; Chakravarthy, K.
    Pain Management (2022)

    Fulltext@MSK | Save
  • Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)
    Review

    Wyatt, K. D.; Birz, S.; Hawkins, D. S.; Minard‐Colin, V.; Rodeberg, D. A.; Sparber‐Sauer, M.; Bisogno, G.; Koscielniak, E.; De Salvo, G. L.; Ebinger, M.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • The Optimal Living Program: Integrating exercise into cancer care
    Meeting Abstract

    Rowed, K.; Shen, S.; Corcoran, S.; Clayton, J.; Kelly, B.; Smith, A.; Emerzian, M.; Cruz, C.; Robson, M.; Iyengar, N.
    Medicine and Science in Sports and Exercise (2022)

    Fulltext@MSK | Save
  • EGFR tyrosine kinase inhibitors and combination strategies in first-line treatment of advanced NSCLC: A network meta-analysis
    Meeting Abstract

    de Castro, G.; Stock, G. T.; Harada, G.; Pereira, A. A. L.; Sadeghirad, B.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • PRO-CTCAE analysis of mobocertinib in EGFR exon 20 insertion‒positive metastatic non‒small cell lung cancer (NSCLC)
    Meeting Abstract

    García Campelo, M. R.; Zhou, C.; Ramalingam, S. S.; Lin, H. M.; Kim, T. M.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Biber, J.; Romero, H.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; Yu, H. A.; Sen, T.; Rudin, C. M.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Extended follow-up of efficacy and safety of larotrectinib in patients with TRK fusion lung cancer
    Meeting Abstract

    Moreno, V.; Lin, J. J.; Tan, D. S. W.; Kummar, S.; Dai, M. S.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Patel, J. D.; Rosen, L.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of BLU-701, a highly selective EGFR inhibitor, in patients with EGFR-mutant non-small cell lung cancer
    Meeting Abstract

    Spira, A.; Spigel, D. R.; Camidge, R.; de Langen, A. J.; Kim, T. M.; Goto, K.; Elamin, Y.; Shum, E.; Reckamp, K. L.; Rotow, J.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • NVL-520, a highly selective ROS1 inhibitor, in patients with advanced ROS1-positive solid tumors: The phase 1/2 ARROS-1 study
    Meeting Abstract

    Drilon, A.; Ou, S. H. I.; Gadgeel, S.; Johnson, M.; Spira, A.; Lopes, G.; Besse, B.; Felip, E.; van der Wekken, A. J.; Calles, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save